Edition:
India

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

11.65USD
16 Jan 2019
Change (% chg)

$0.17 (+1.48%)
Prev Close
$11.48
Open
$11.57
Day's High
$12.27
Day's Low
$11.53
Volume
176,579
Avg. Vol
251,835
52-wk High
$20.85
52-wk Low
$9.51

Chart for

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $863.35
Shares Outstanding(Mil.): 67.71
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates